GlassScriptPhysician profile
Melissa Brown
NPI 1720574643
$2,640.72
in general payments reported to CMS, 2019-2025
19 companies · $534 in 2025
The $534 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $1,430 · 2023: $228 · 2024: $300 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.05 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,635.86 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $165.07 | 2025 | Axonics |
| Janssen Biotech, INC. | $102.90 | 2023-2025 | Erleada |
| Urogen Pharma, INC. | $84.59 | 2024-2025 | |
| Baxter Healthcare | $77.90 | 2022-2023 | Preveleak |
| Abbvie INC. | $76.84 | 2024-2025 | |
| Astellas Pharma US INC | $72.59 | 2021-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $71.19 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $69.03 | 2023-2025 | Porges Coloplast |
| Endo USA, INC. | $66.19 | 2024-2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $40.19 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myovant Sciences INC. | $31.62 | 2022 | |
| Ferring Pharmaceuticals INC. | $24.72 | 2025 | Adstiladrin |
| Urovant Sciences INC | $23.88 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $19.58 | 2022 | |
| Davol INC. | $14.92 | 2022 | |
| Photocure INC | $14.46 | 2023 | Cysview |
| Pfizer INC. | $14.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.